1. Home /
  2. Markets /
  3. Regulation

Regulation  

Why Macy's Is at Risk of Losing Its Shirt

Earnings misses, bad planning, and product-line execution problems are all hitting the retailer, but it's the macro woes that will also hurt its competitors.

Earnings to Tell Whether Cannabis' High Growth Story Is Going to Pot

After a 2018 high, marijuana stocks are gaining popularity again, but which ones are producing the most green for investors? Here are the charts.

A Look at Mylan's New Post-Merger Management

What new management means for Mylan shareholders moving forward.

Mylan Jumps on Deal With Pfizer to Form New Company

Pfizer will combine its off-patent drug business with Mylan in the as-yet-to-be-named new company.

Alphabet Shares Soar After Excellent Earnings Results

A big jump in the market cap of Google's parent is in store thanks to an impressive second-quarter report.

Tesla Tanks as Profitability Problems Persist, Another Executive Exits

Volatility reigns once again at the electric carmaker, which is seeing JB Straubel depart as chief technology officer.

Interesting Small-Cap Charts Are Developing Into Earnings

Big-cap names have been driving the market, but some small-caps could make noise, too.

Feds Probe Tech, Mueller Speaks, Holy Guacamole and Now Hear NOW: Market Recon

Watch closely as the government opens a broad antitrust investigation into unidentified leading online technology platforms

CannTrust Is Caught in a Cannabis Catch-22

The loss of clients is a primary concern here.

What Trump's Bank Charter Challenge Means for Facebook's Libra

It is unclear how a 'libra' denominated transaction might be governed in the future and it might require the creation of an entirely new oversight entity.

Facebook Falters Amid Political Pressure on Libra Digital Currency

Surprise, surprise: Regulatory opposition toward digital currencies at home and abroad is rising against Facebook.

Deutsche Bank Stock Declines as Transformation Plan Sinks In

Deutsche is looking to drop the "bad bank" moniker with big moves on Monday.

2 Attractive Biotechs With Key Study Outcomes on the Horizon

Intra-Cellular Therapies and Acadia Pharmaceuticals are worth investors' attention.

Boeing Loses Altitude as FAA Finds More Risks Related to 737 MAX

The Federal Aviation Administration has declined to set a timeline on when it will lift its order prohibiting the troubled aircraft from flying.

Trump-Xi Face Off, Potential EU Land Mines and a Caterpillar Play: Market Recon

The G-20 Summit in Japan could hold more intrigue than just the planned meeting between President Trump and Xi.

Micron's Surge Causes Skeptics to Step Back

A number of vocal analysts and investors are calling for caution on those eager to buy the semiconductor stock amidst its Wednesday morning leap.

Micron's Unexpected Move Higher Boosts Semiconductor Sentiment

Micron is motivating more positive outlook on the semiconductor sector's road ahead.

Wall Street Voices Skepticism on AbbVie's Aggressive Allergan Acquisition

Despite the financial positivity, many analysts warn the deal could have hiccups ahead.

Think AbbVie Is Overpaying for Allergan? Pfizer Offered Way More in 2015

PFE was ready to pay $160 billion until U.S. regulators blocked the deal.

AbbVie Joins Giant Acquisition Trend in Big Pharma With Allergan Deal

The proposed, $63 billion transaction is the latest deal in an industry where it can be cheaper to buy the science of another company than develop products.

Charts of the Day: The States of U.S. Gambling

A bit of context to simmer on following the big deal between Caesars and Eldorado.

Prohibition and the Paradoxical Proclivity of Cannabis Consumption

Is prohibition the real factor propping up projections for demand and pricing in the cannabis market?

Can Oracle Retake Lost Market Share -- Or Is It In the Clouds?

Oracle tells investors it can regain the crown it once held among enterprises and end-users, but some aren't so sure.

Wall Street Is Still Waiting on the Oracle Debate to Settle

Is the bad news for Oracle all over?

Tencent-Backed WeDoctor Scraps International Listing for Shanghai

The healthcare app creator reportedly shelves a Hong Kong listing in favor of "China's Nasdaq" due to data privacy and transparency concerns.

Slack Marches to the Beat of a Different Drum in Unicorn Parade

Will Slack help set a new trend for IPO strategy among red-hot technology companies?

Is Facebook's Blockchain Bet the Next Big Thing in Big Tech?

Is Libra the next tectonic shift in tech? Is it even a cryptocurrency at all?

Libra: What You Need to Know About Facebook's New Cryptocurrency

Facebook's first blockchain-backed payment initiative is here. Here's what investors and crypto enthusiasts need to know.

Can Instagram Survive Independent From Facebook?

Is breaking up big tech just another big headache?

Chewy's Dual-Class Structure Isn't Ideal for Investors

Chewy is challenging strong criticism with its disparate dual-class structure.